Free Trial
Your Rate Never Goes Up! Save $100 a Year on MarketBeat All Access
Upgrade Now
Claim MarketBeat All Access Sale Promotion

Citigroup's Rating of Moderna on 10/23/2026

On October 23, 2026, Citigroup updated its outlook on Moderna (NASDAQ:MRNA) with the action "Reiterated Rating", keeping a "Sell" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Citigroup Inc.

DateCompanyAction
10/23/2026
Nokia Corporation stock logo
NOK
Nokia
Reiterated Rating
10/23/2026
VeriSign, Inc. stock logo
VRSN
VeriSign
Reiterated Rating
10/23/2026
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
Reiterated Rating
10/23/2026
Dow Inc. stock logo
DOW
DOW
Reiterated Rating
10/23/2026
Texas Roadhouse, Inc. stock logo
TXRH
Texas Roadhouse
Reiterated Rating
10/23/2026
Sweetgreen, Inc. stock logo
SG
Sweetgreen
Reiterated Rating
More Ratings From Citigroup Inc.